Literature DB >> 18835493

Neoadjuvant chemotherapy and conservative surgery for stage IB1 cervical cancer.

Andrea Maneo1, Stefania Chiari, Cristina Bonazzi, Costantino Mangioni.   

Abstract

OBJECTIVES: To assess the effectiveness of chemo-surgical conservative therapy for stage IB1 cervical tumors in patients desiring to preserve fertility.
METHODS: From 1995 to April 2007 51 nulliparous patients with tumor <or=3 cm, aged <or=40 years with no uterine and lymphnode neoplastic involvement were evaluated. Three courses with cisplatin 75 mg/m(2), paclitaxel 175 mg/m(2) and ifosfamide 5 g/m(2) (epirubicin 80 mg/m(2) in adenocarcinoma) were followed by cold-knife conization and pelvic lymphadenectomy. When intraoperative frozen section revealed massive neoplastic cervical persistence a radical total hysterectomy was performed.
RESULTS: Thirty women (59%) did not accept the conservative approach. In the remaining 21 patients median age was 30 years and median tumor size was 15 mm (range 10-30 mm). Adenocarcinoma was present in 12 cases (57%) and indifferentiated neoplasia in 10 (48%). Following neoadjuvant treatment, pathological complete response was observed in 5 cases, in situ or microinvasive residue in 12 and stromal invasion >3 mm in 4. Four women deemed ineligible for conservative surgery after chemotherapy and one refusing to preserve her genital apparatus underwent radical hysterectomy. After a median follow-up of 69 months no relapses were observed. Nine women attempted to conceive: ten pregnancies occurred in 6 patients and 9 live babies have been born, while one woman experienced a first-trimester miscarriage.
CONCLUSIONS: The high rate of pathological response confirms the effectiveness of the preoperative treatment for reducing the tumor volume allowing the removal only of a cervical cone instead of the entire cervix with cardinal ligaments as needed by radical trachelectomy. Successful pregnancies are possible after such integration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18835493     DOI: 10.1016/j.ygyno.2008.08.023

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  27 in total

1.  Asian society of gynecologic oncology workshop 2010.

Authors:  Dong Hoon Suh; Jae Weon Kim; Mohamad Farid Aziz; Uma K Devi; Hextan Y S Ngan; Joo-Hyun Nam; Seung Cheol Kim; Tomoyasu Kato; Hee Sug Ryu; Shingo Fujii; Yoon Soon Lee; Jong Hyeok Kim; Tae-Joong Kim; Young Tae Kim; Kung-Liahng Wang; Taek Sang Lee; Kimio Ushijima; Sang-Goo Shin; Yin Nin Chia; Sarikapan Wilailak; Sang Yoon Park; Hidetaka Katabuchi; Toshiharu Kamura; Soon-Beom Kang
Journal:  J Gynecol Oncol       Date:  2010-09-28       Impact factor: 4.401

2.  Surgical management of early cervical cancer: the shape of future studies.

Authors:  Stefano Greggi; Cono Scaffa
Journal:  Curr Oncol Rep       Date:  2012-12       Impact factor: 5.075

3.  A phase I study of adjuvant intensity-modulated radiotherapy with concurrent paclitaxel and cisplatin for cervical cancer patients with high risk factors.

Authors:  Pei Shu; Yali Shen; Yaqin Zhao; Feng Xu; Meng Qiu; Qiu Li; Hongfeng Gou; Dan Cao; Yu Yang; Jiyan Liu; Cheng Yi; Zhengyin Liao; Deyun Luo; Feng Bi; Xin Wang; Zhiping Li
Journal:  Med Oncol       Date:  2015-10-03       Impact factor: 3.064

Review 4.  Review of neoadjuvant chemotherapy and trachelectomy: which cervical cancer patients would be suitable for neoadjuvant chemotherapy followed by fertility-sparing surgery?

Authors:  Helena Robova; Lukas Rob; Michael Jiri Halaska; Marek Pluta; Petr Skapa
Journal:  Curr Oncol Rep       Date:  2015       Impact factor: 5.075

Review 5.  Fertility preserving options in patients with gynecologic malignancies.

Authors:  Ramez N Eskander; Leslie M Randall; Michael L Berman; Krishnansu S Tewari; Philip J Disaia; Robert E Bristow
Journal:  Am J Obstet Gynecol       Date:  2011-03-16       Impact factor: 8.661

Review 6.  Pharmacotherapy options for locally advanced and advanced cervical cancer.

Authors:  Alfonso Dueñas-González; Lucely Cetina; Jaime Coronel; Déborah Martínez-Baños
Journal:  Drugs       Date:  2010-03-05       Impact factor: 9.546

Review 7.  Conservative management of early stage cervical cancer: is there a role for less radical surgery?

Authors:  Kathleen M Schmeler; Michael Frumovitz; Pedro T Ramirez
Journal:  Gynecol Oncol       Date:  2011-03       Impact factor: 5.482

8.  Neoadjuvant chemotherapy followed by conization to spare fertility in cases of locally advanced cervical cancer: A case report and review of the literature.

Authors:  Yanling Feng; Tiefeng Cao; Yin Wang; He Huang; Yujie Xie; Jihong Liu
Journal:  Mol Clin Oncol       Date:  2016-08-01

Review 9.  Fertility-Sparing Options in Young Women with Cervical Cancer.

Authors:  Federica Tomao; Giacomo Corrado; Fedro Alessandro Peccatori; Sara Boveri; Eleonora Petra Preti; Nicoletta Colombo; Fabio Landoni
Journal:  Curr Treat Options Oncol       Date:  2016-01

Review 10.  Taxanes: their impact on gynecologic malignancy.

Authors:  Carlton L Schwab; Diana P English; Dana M Roque; Alessandro D Santin
Journal:  Anticancer Drugs       Date:  2014-05       Impact factor: 2.248

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.